Home Page
21:43:12 EST Sun 23 Nov 2014
Enter Symbol
or Name
USA
CA



ALLIED HEALTHCARE PROD INC
Symbol U : AHPI
Recent Sedar Documents

Allied Healthcare Products Reports Break-Even Quarter

2012-02-13 16:25 ET - News Release

ST. LOUIS, Feb. 13, 2012/PRNewswire/ --With its markets still facing tight budget constraints, Allied Healthcare Products (NASDAQ: AHPI) reported break-even results for the second quarter of fiscal year 2012.

Net income for the quarter ending December 31, was about $23,000, or zero cents per basic and diluted share, versus $117,000, or 1 cent per basic and diluted share for the prior year. Sales for the quarter declined from about $11.4 million to $10.7 million, or about 6.1 percent, from the previous year.

For the first two quarters of fiscal 2012, net income was a negative $122,000, or a negative 2 cents per basic and diluted share, compared to net income of $29,000, or zero cents per basic and diluted share, for the prior year. Sales for the first two quarters slipped from about $23.3 million to $22.1 million, or about 5.2 percent, from the previous year.

Sales declines in other markets were partially offset by increases in domestic hospital construction and international markets of 12 and 4 percent, respectively, Allied reported.  

Increases in costs for commodities such as brass and plastic resin totaled about 8 percent or $110,000 in the first two quarters. Material cost increases were offset by cost reduction projects which reduced manufacturing costs by $160,000 for the two quarters.

"We expect to achieve further cost reductions in operations in the second half of the fiscal year from projects we have underway," said Earl Refsland, Allied Healthcare Products president and chief executive officer.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical product dealers.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements."  Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.


ALLIED HEALTHCARE PRODUCTS, INC.

CONSOLIDATED STATEMENT OF OPERATIONS

(UNAUDITED)










Three months ended,


Six months ended,


December 31,


December 31,


2011


2010


2011


2010









Net sales

$10,681,395


$11,402,681


$22,076,403


$23,343,414

Cost of sales

7,946,458


8,592,712


16,935,449


17,982,718

Gross profit

2,734,937


2,809,969


5,140,954


5,360,696

















Selling General and administrative expenses

2,693,894


2,600,734


5,327,983


5,285,310

Income (loss) from operations

41,043


209,235


(187,029)


75,386

















Interest income

(7,297)


(8,067)


(16,292)


(15,542)

Interest expense

-


-


336


66

Other, net

11,743


28,410


26,149


43,509


4,446


20,343


10,193


28,033









Income (loss) before provision for








(benefit from) income taxes

36,597


188,892


(197,222)


47,353









Provision for (benefit from) income taxes

13,907


71,779


(74,944)


17,994

Net income (loss)

$22,690


$117,113


($122,278)


$29,359









Net income (loss) per share - Basic

$0.00


$0.01


($0.02)


$0.00









Net income (loss) per share - Diluted

$0.00


$0.01


($0.02)


$0.00









Weighted average common shares outstanding - Basic

8,124,386


8,098,366


8,124,386


8,095,876









Weighted average common shares outstanding - Diluted

8,124,834


8,119,386


8,124,386


8,114,724
















ALLIED HEALTHCARE PRODUCTS, INC.


CONSOLIDATED BALANCE SHEET


(UNAUDITED)








December 31, 2011


June 30, 2011

ASSETS




Current assets:





Cash and cash equivalents

$            6,251,364


$          6,512,887


Accounts receivable, net of allowances





 of $300,000

4,211,786


5,366,860


Inventories, net

11,072,733


10,553,289


Income tax receivable

169,507


95,578


Other current assets

503,979


213,745


   Total current assets

22,209,369


22,742,359


Property, plant and equipment, net

8,952,244


8,660,507


Other assets, net

356,359


362,480


   Total assets

$          31,517,972


$        31,765,346






LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:





Accounts payable

$            2,027,981


$          1,644,910


Other accrued liabilities

1,468,468


1,645,552


Deferred income taxes

503,894


512,572


Deferred revenue

458,800


688,200


   Total current liabilities

4,459,143


4,491,234






Deferred revenue

-


114,700






Commitments and contingencies









Stockholders' equity:





Preferred stock; $0.01 par value; 1,500,000 shares

-


-


 authorized; no shares issued and outstanding





Series A preferred stock; $0.01 par value; 200,000 shares

-


-


 authorized; no shares issued and outstanding





Common stock; $0.01 par value; 30,000,000 shares





 authorized; 10,427,878 shares issued at December 31,





 2011 and June 30, 2011; 8,124,386 shares outstanding





 at December 31, 2011 and June 30, 2011

104,279


104,279


Additional paid-in capital

48,520,798


48,499,103


Accumulated deficit

(834,820)


(712,542)


Less treasury stock, at cost; 2,303,492 shares at





  December 31, 2011 and June 30, 2011

(20,731,428)


(20,731,428)


   Total stockholders' equity

27,058,829


27,159,412


   Total liabilities and stockholders' equity

$          31,517,972


$        31,765,346




SOURCE Allied Healthcare Products

© 2014 Canjex Publishing Ltd. All rights reserved.